Algert Global’s Otonomy, Inc. OTIC Stock Holding History

Algert Global’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,750	Closed	-$41K	–	1355
2021 Q4	$41K	Buy	19,750 +6,410	+48%	+$13.2K	0.01%	939
2021 Q3	$26K	Buy	+13,340	New	+$22.6K	﹤0.01%	1004
2021 Q2	–	Sell	-85,259	Closed	-$217K	–	564
2021 Q1	$217K	Buy	+85,259	New	+$349K	0.07%	364

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Algert Global's OTIC Position: Q1 2022 in Review

Algert Global sold out of Otonomy, Inc. (OTIC) in Q1 2022, closing a stake of 19,750 shares — an estimated $41K sold.

Algert Global first reported a position in OTIC in Q1 2021 and held it in 3 quarters. The position peaked at $217K in Q1 2021. 50 funds tracked by Wall St. Rank hold OTIC as of Q1 2022.

Algert Global reported no remaining Otonomy, Inc. position as of Q1 2022 after selling out during the quarter.
Algert Global sold 19,750 Otonomy, Inc. shares in Q1 2022, an estimated $41K.
Algert Global first reported a position in Otonomy, Inc. in Q1 2021 and held it in 3 quarters.
Algert Global's Otonomy, Inc. position peaked at $217K in Q1 2021.
50 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.